BLCO
Bausch + Lomb Corp.

522
Mkt Cap
$5.18B
Volume
267,087.00
52W High
$20.71
52W Low
$10.45
PE Ratio
-16.93
BLCO Fundamentals
Price
$14.57
Prev Close
$14.62
Open
$14.81
50D MA
$15.19
Beta
1.08
Avg. Volume
486,489.61
EPS (Annual)
-$0.9011
P/B
0.81
Rev/Employee
$354,888.89
Loading...
Loading...
News
all
press releases
Bausch + Lomb to Participate in Citi Global Healthcare Conference
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and...
Business Wire·2d ago
News Placeholder
More News
News Placeholder
Bausch + Lomb (NYSE:BLCO) Given New $19.00 Price Target at Royal Bank Of Canada
Royal Bank Of Canada raised their price objective on Bausch + Lomb from $17.00 to $19.00 and gave the company an "outperform" rating in a research note on Friday...
MarketBeat·5d ago
News Placeholder
Wells Fargo & Company Increases Bausch + Lomb (NYSE:BLCO) Price Target to $17.00
Wells Fargo & Company raised their price target on Bausch + Lomb from $16.00 to $17.00 and gave the company an "equal weight" rating in a report on Friday...
MarketBeat·5d ago
News Placeholder
NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership
NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership PR Newswire NEW YORK, Nov. 13...
PR Newswire·7d ago
News Placeholder
Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical
Bausch + Lomb CEO Brent Saunders joins 'Squawk Box' to preview the company's investor day, details of the company's three-year plan for profitable growth, impact of tariffs, and more...
CNBC Television-YouTube·7d ago
News Placeholder
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will outline the next chapter of its evolution today during an...
Business Wire·7d ago
News Placeholder
BLCO Crosses Above Average Analyst Target
In recent trading, shares of Bausch + Lomb Corporation (Symbol: BLCO) have crossed above the average analyst 12-month target price of $16.14, changing hands for $16.43/share. When a stock reaches the...
Nasdaq News: Markets·8d ago
News Placeholder
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program...
Business Wire·10d ago
News Placeholder
Bausch + Lomb to Hold Investor Day on Nov. 13
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New...
Business Wire·17d ago
News Placeholder
Bausch + Lomb (BLCO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·22d ago

Latest BLCO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.